Cantor Fitzgerald Adjusts Capricor Therapeutics Price Target to $25 From $8, Maintains Overweight Rating; Shares Rise
Cantor Fitzgerald Adjusts Capricor Therapeutics Price Target to $25 From $8, Maintains Overweight Rating; Shares Rise
康特菲茨調整了capricor therapeutics的目標股價,從8美元上調至25美元,維持股票超重評級;股價上漲
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊